Loading Curie Briefs...
Getting the latest healthcare news for you
Getting the latest healthcare news for you
Women are disproportionately affected by rheumatic diseases yet face longer diagnostic delays, longer wait times, and undertreated symptoms — often because of invisible gender bias. A new viewpoint in Annals of the Rheumatic Diseases calls out the problem and offers practical steps for rheumatologists to close the gap. From better EHR documentation to simply asking patients about caregiving burdens, small changes can make a big difference.
Women develop rheumatic and musculoskeletal diseases (RMDs) at significantly higher rates than men — yet they consistently face longer diagnostic delays, longer wait times, and less access to advanced therapies. A new viewpoint published in Annals of the Rheumatic Diseases argues that much of this disparity stems from gender bias that is often invisible, even to the clinicians perpetuating it. Historically, diagnostic criteria were built around how diseases present in men, and women's pain has long been normalized or dismissed as stress or anxiety.
The problem doesn't stop at the clinic door. Caregiving responsibilities — shouldered by women 66% of the time — can delay appointment-seeking, and psychosocial stress has been linked to elevated autoimmune disease risk in postmenopausal women. Reproductive health concerns are also frequently overlooked in rheumatology visits, though a recent study showed that simple EHR workflow changes and medical assistant involvement can dramatically improve documentation of contraception and pregnancy intent.
By the Numbers:
Why it matters: Gender bias in rheumatology isn't just a fairness issue — it leads to real delays in diagnosis and treatment that worsen long-term outcomes. Experts say rheumatologists can start closing the gap today by auditing their own data, training staff on bias, and asking patients about caregiving burdens and reproductive health.
